HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naif O Al-Harbi Selected Research

Drug-Related Side Effects and Adverse Reactions

3/2020Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naif O Al-Harbi Research Topics

Disease

50Inflammation (Inflammations)
12/2023 - 08/2014
15Autistic Disorder (Autism)
08/2023 - 03/2017
13Asthma (Bronchial Asthma)
11/2023 - 05/2015
12Psoriasis (Pustulosis Palmaris et Plantaris)
12/2023 - 09/2015
8Acute Lung Injury
06/2022 - 12/2015
8Cardiotoxicity
04/2020 - 09/2014
5Multiple Myeloma
08/2019 - 01/2016
4Lung Injury
07/2023 - 01/2015
4Sepsis (Septicemia)
04/2023 - 05/2018
4Acute Kidney Injury (Acute Renal Failure)
10/2021 - 05/2018
3Pneumonia (Pneumonitis)
07/2023 - 11/2018
3Wounds and Injuries (Trauma)
01/2023 - 01/2014
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2023 - 06/2021
2Neuroinflammatory Diseases
04/2023 - 01/2018
2Autism Spectrum Disorder
03/2023 - 01/2022
2Neoplasms (Cancer)
04/2022 - 01/2019
2Otitis
01/2022 - 01/2017
1Psoriatic Arthritis
07/2023
1Dysbiosis
02/2023
1Demyelinating Diseases (Demyelinating Disease)
01/2023
1Optic Neuritis (Retrobulbar Neuritis)
01/2023
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Cardiomegaly (Heart Hypertrophy)
01/2021

Drug/Important Bio-Agent (IBA)

21AntioxidantsIBA
12/2023 - 12/2013
20CytokinesIBA
12/2023 - 06/2015
13Imiquimod (Aldara)FDA LinkGeneric
12/2023 - 09/2015
13Oxidants (Oxidizing Agents)IBA
12/2023 - 08/2014
13Interleukin-17 (Interleukin 17)IBA
12/2023 - 05/2016
113-nitrotyrosineIBA
11/2023 - 04/2016
11Peroxidase (Myeloperoxidase)IBA
06/2020 - 09/2015
9Lipid PeroxidesIBA
04/2023 - 05/2015
8Proteins (Proteins, Gene)FDA Link
04/2023 - 12/2013
8NADPH Oxidases (NAD(P)H oxidase)IBA
02/2021 - 04/2016
7AllergensIBA
11/2023 - 04/2016
7apremilastIBA
07/2023 - 11/2016
6phthalic acid (phthalate)IBA
12/2023 - 12/2020
6Diethylhexyl Phthalate (DEHP)IBA
12/2023 - 01/2018
6EnzymesIBA
11/2023 - 12/2013
6Biomarkers (Surrogate Marker)IBA
07/2019 - 12/2013
5Environmental Pollutants (Pollutants, Environmental)IBA
12/2023 - 01/2021
5Dexamethasone (Maxidex)FDA LinkGeneric
06/2023 - 05/2016
5Adrenal Cortex Hormones (Corticosteroids)IBA
06/2023 - 01/2018
5Transcription Factors (Transcription Factor)IBA
10/2021 - 09/2015
5carfilzomibIBA
08/2019 - 01/2016
4LipopolysaccharidesIBA
07/2023 - 01/2015
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2023 - 10/2019
4ibrutinibIBA
04/2023 - 10/2019
4Agammaglobulinaemia Tyrosine KinaseIBA
04/2023 - 10/2019
4Phosphotransferases (Kinase)IBA
01/2022 - 10/2019
4CreatinineIBA
10/2021 - 05/2017
4Proteasome InhibitorsIBA
08/2019 - 11/2016
4Interleukin-6 (Interleukin 6)IBA
01/2019 - 06/2015
3ChemokinesIBA
09/2023 - 11/2018
3LipidsIBA
07/2023 - 01/2017
31-methyl-1H-indole-2-carboxylic acid (4- (1- (4- (4- acetylpiperazin- 1- yl)cyclohexyl)- 4- amino- 1H- pyrazolo(3,4- d)pyrimidin- 3- yl)- 2- methoxyphenyl)amideIBA
06/2023 - 01/2022
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2022 - 10/2018
3PlasticizersIBA
01/2021 - 01/2018
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2020 - 04/2016
3Rutin (Rutoside)IBA
08/2019 - 01/2014
3NitrogenIBA
03/2019 - 05/2017
3Syk KinaseIBA
03/2019 - 03/2019
3Urea (Carbamide)FDA LinkGeneric
03/2019 - 05/2017
3Carbon Tetrachloride (Tetrachloromethane)IBA
01/2017 - 01/2014
2ThioredoxinsIBA
08/2023 - 02/2023
2Thioredoxin Reductase 1IBA
08/2023 - 02/2023
2Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
07/2023 - 01/2022
2NF-kappa B (NF-kB)IBA
06/2023 - 10/2018
2DNA (Deoxyribonucleic Acid)IBA
03/2023 - 01/2021
2Interleukin-10 (Interleukin 10)IBA
10/2021 - 06/2020
2Carnitine (L-Carnitine)FDA LinkGeneric
01/2021 - 01/2012
2Messenger RNA (mRNA)IBA
01/2021 - 01/2016
2Toll-Like Receptor 4IBA
07/2020 - 03/2017
2sulforaphaneIBA
07/2019 - 01/2019
2Glutathione Transferase (Glutathione S-Transferase)IBA
07/2019 - 01/2015
2Acetates (Acetic Acid Esters)FDA Link
05/2018 - 01/2017
2Interleukin-17 ReceptorsIBA
01/2018 - 01/2017
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2017 - 12/2014
2aliskirenFDA Link
12/2015 - 12/2014
2Tacrolimus (Prograf)FDA LinkGeneric
12/2015 - 12/2014
2Immunosuppressive Agents (Immunosuppressants)IBA
12/2015 - 12/2014
2Renin InhibitorsIBA
12/2015 - 12/2014
2IfosfamideFDA LinkGeneric
09/2014 - 01/2012
1Thioredoxin-Disulfide ReductaseIBA
09/2023
1methylmercuric chlorideIBA
06/2023
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2023
1Sucrose (Saccharose)IBA
04/2023
1Histone Deacetylase 2IBA
04/2023
1Peptides (Polypeptides)IBA
01/2023
1Cathepsin BIBA
01/2023
1N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA
01/2023
1Myelin Basic ProteinIBA
01/2023
1AcidsIBA
06/2022
1geraniol (nerol)IBA
04/2022
1p38 Mitogen-Activated Protein KinasesIBA
01/2022
1statticIBA
06/2021
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2021
1Insulin (Novolin)FDA Link
01/2021

Therapy/Procedure

12Therapeutics
06/2023 - 01/2012
1Immunomodulation
07/2023